High materiality7/10
Monopar Therapeutics price target raised to $133 from $117 at BTIG
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
MNPR target raised to $133; current price around $114.90.
- Target raised to $133; price $114.90
- BTIG upgrades MNPR target to $133
Key facts
- 01
Target: $133
- 02
Posted price: $114.9
- 03
Analyst firm: BTIG
- 04
Analyst: Jeet Mukherjee
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.